From: MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
Timing of Treatment Recommendations | Concordance of Treatment Recommendations with 70-GS Results | |||
---|---|---|---|---|
All Patients | Concordant | Discordant | Total | p-value |
Pre-MINDACT | 91 (84.3%) | 17 (15.7%) | 108 | p = 0.094 |
Post-MINDACT | 226 (90.4%) | 24 (9.6%) | 250 | |
70-GS Low Risk Patients | ||||
Pre-MINDACT | 55 (88.7%) | 7 (11.3%) | 62 | p = 0.351 |
Post-MINDACT | 150 (92.6%) | 12 (7.4%) | 162 | |
70-GS High Risk Patients | ||||
Pre-MINDACT | 36 (78.3%) | 10 (21.7%) | 46 | p = 0.229 |
Post-MINDACT | 76 (86.3%) | 12 (13.6%) | 88 |